Aeon Global Health (OTCMKTS:AGHC) Shares Down 14.4%

Aeon Global Health Corp (OTCMKTS:AGHC) was down 14.4% during mid-day trading on Monday . The company traded as low as $0.16 and last traded at $0.30. Approximately 3,111 shares traded hands during trading, an increase of 23% from the average daily volume of 2,520 shares. The stock had previously closed at $0.35.

Separately, Zacks Investment Research upgraded shares of Aeon Global Health from a “sell” rating to a “hold” rating in a research report on Wednesday, February 27th.

The firm’s 50-day moving average is $0.21. The company has a debt-to-equity ratio of 1.43, a quick ratio of 0.42 and a current ratio of 0.48.

Aeon Global Health Company Profile (OTCMKTS:AGHC)

Aeon Global Health Corp., together with its subsidiaries, provides various clinical laboratory testing services in the United States. The company operates through Laboratory Testing Services and Web-Based Software segments. Its laboratory testing services include the testing of an individual's blood, urine, or saliva for the presence of drugs or chemicals, as well as the patient's DNA profile.

Featured Article: Preferred Stock

Receive News & Ratings for Aeon Global Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeon Global Health and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply